A replica of a woman's brain aneurysm allowed doctors to practice several times before operating on her.» Read More
Johnson & Johnson delivered quarterly earnings that topped analysts' expectations on Tuesday.
Newly eligible enrollees are costing an average of $5,517 per person, almost 20 percent above earlier estimates.
The FDA strengthens the warning on well-known pain relievers, but will it impact the big money behind those popular pills?
Jeb Bush won the tweet-off about American workers, says Larry Kudlow, and Hillary is just wrong.
Five audits detailed mistakes in almost two-thirds of payments the government made.
Just 11.4 percent of Americans lack health insurance, a nearly 6 percentage-point plunge since 2013.
Andy Slavitt, the acting boss of the Centers for Medicare and Medicaid Services, which oversees Obamacare, has been nominated as head of the agency.
The Supreme Court ruled on Obamacare. Now, all the states need to fall in line, three House Dems say.
The FDA is strengthening its warnings about painkillers like ibuprofen, saying they do raise the risk of heart attack or stroke.
The federal government wants many hospitals to be paid on outcomes for hip and knee replacement surgeries.
Spending on kids grew by 5.7 percent annually over three years, compared with just 3.9 percent for everyone up to age 64.
American women are spending less out of pocket for birth control, with more savings on the horizon.
Blue Shield of California had stowed away more than $4 billion, an amount that raised concerns for state tax regulators.
Horizon Pharma said it offered to buy Depomed for about $3 billion, taking its bid hostile after the smaller drugmaker rejected the first proposal.
A record amount of money surged into digital health start-ups last year, and in 2015, the capital continues to rush into these private companies.
The Aetna and Humana tie-up promises to impact consumers, hospitals and doctors as the companies look for ways to cut costs.
Health insurers are seeking steep rate increases, saying their new customers under the Affordable Care Act turned out to be sicker than expected.
Amid a big era for consolidation in the health insurance sector, will the M&A wave spur more deals?
The FDA approved the use of Vertex Pharmaceuticals' Orkambi, a drug aimed to treat patients with cystic fibrosis.
With a modified tattoo machine, one eye surgeon is tattooing blind patients’ eyes to match their natural eye color.
Get the best of CNBC in your inbox